Amina Aït-Ammar

759 total citations
10 papers, 310 citations indexed

About

Amina Aït-Ammar is a scholar working on Virology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Amina Aït-Ammar has authored 10 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Virology, 7 papers in Molecular Biology and 4 papers in Infectious Diseases. Recurrent topics in Amina Aït-Ammar's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (3 papers) and RNA Research and Splicing (3 papers). Amina Aït-Ammar is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (3 papers) and RNA Research and Splicing (3 papers). Amina Aït-Ammar collaborates with scholars based in Belgium, France and Ireland. Amina Aït-Ammar's co-authors include Olivier Rohr, Carine Van Lint, Roxane Verdikt, Christian Schwartz, Fadoua Daouad, Virginie Gautier, Gilles Darcis, Anna Kula, Patrick Mallon and Christoph Stephan and has published in prestigious journals such as Nucleic Acids Research, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Amina Aït-Ammar

9 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amina Aït-Ammar Belgium 8 239 125 114 97 48 10 310
Oussama Méziane Canada 8 179 0.7× 86 0.7× 256 2.2× 76 0.8× 45 0.9× 13 416
Roxane Verdikt Belgium 7 162 0.7× 100 0.8× 104 0.9× 71 0.7× 30 0.6× 15 235
Anouk Van Nuffel Belgium 6 229 1.0× 109 0.9× 97 0.9× 142 1.5× 64 1.3× 8 324
Narasimhan J. Venkatachari United States 13 299 1.3× 158 1.3× 173 1.5× 207 2.1× 84 1.8× 16 498
Corinna Pade United Kingdom 10 117 0.5× 120 1.0× 131 1.1× 86 0.9× 41 0.9× 15 333
Claire Veryard United Kingdom 4 106 0.4× 78 0.6× 57 0.5× 67 0.7× 35 0.7× 6 192
Bastian Grewe Germany 11 179 0.7× 49 0.4× 188 1.6× 75 0.8× 25 0.5× 12 312
Tahar Babas United States 10 339 1.4× 149 1.2× 91 0.8× 106 1.1× 145 3.0× 14 412
Megan A. O’Connor United States 11 139 0.6× 87 0.7× 92 0.8× 161 1.7× 140 2.9× 26 361
Yoshimi Enose Japan 11 230 1.0× 118 0.9× 80 0.7× 138 1.4× 107 2.2× 23 401

Countries citing papers authored by Amina Aït-Ammar

Since Specialization
Citations

This map shows the geographic impact of Amina Aït-Ammar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Aït-Ammar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Aït-Ammar more than expected).

Fields of papers citing papers by Amina Aït-Ammar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina Aït-Ammar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Aït-Ammar. The network helps show where Amina Aït-Ammar may publish in the future.

Co-authorship network of co-authors of Amina Aït-Ammar

This figure shows the co-authorship network connecting the top 25 collaborators of Amina Aït-Ammar. A scholar is included among the top collaborators of Amina Aït-Ammar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina Aït-Ammar. Amina Aït-Ammar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rovere, Marco De, Amina Aït-Ammar, Muhammad Kashif, et al.. (2024). BCL11b interacts with RNA and proteins involved in RNA processing and developmental diseases. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1867(4). 195065–195065.
2.
Krijger, Peter H.L., Benoît Van Driessche, Caroline Vanhulle, et al.. (2022). Role of the cellular factor CTCF in the regulation of bovine leukemia virus latency and three-dimensional chromatin organization. Nucleic Acids Research. 50(6). 3190–3202. 8 indexed citations
3.
Aït-Ammar, Amina, Fadoua Daouad, Valérie Martinelli, et al.. (2021). Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage. Scientific Reports. 11(1). 2692–2692. 25 indexed citations
4.
Lange, Ulrike C., Roxane Verdikt, Amina Aït-Ammar, & Carine Van Lint. (2020). Epigenetic crosstalk in chronic infection with HIV-1. Seminars in Immunopathology. 42(2). 187–200. 24 indexed citations
5.
Aït-Ammar, Amina, Anna Kula, Gilles Darcis, et al.. (2020). Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs. Frontiers in Microbiology. 10. 3060–3060. 108 indexed citations
6.
Ali, Sultan, Clémentine Wallet, Marco De Rovere, et al.. (2019). HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing. Scientific Reports. 9(1). 13154–13154. 21 indexed citations
7.
Verdikt, Roxane, Gilles Darcis, Amina Aït-Ammar, & Carine Van Lint. (2019). Applications of CRISPR/Cas9 tools in deciphering the mechanisms of HIV-1 persistence. Current Opinion in Virology. 38. 63–69. 4 indexed citations
8.
Douce, Valentin Le, Sebastian Eilebrecht, Benoît Van Driessche, et al.. (2016). HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1. Scientific Reports. 6(1). 34920–34920. 21 indexed citations
9.
Douce, Valentin Le, Amina Aït-Ammar, Fadoua Daouad, et al.. (2016). Improving combination antiretroviral therapy by targeting HIV-1 gene transcription. Expert Opinion on Therapeutic Targets. 20(11). 1311–1324. 13 indexed citations
10.
Aït-Ammar, Amina, et al.. (2016). Targeting the Brain Reservoirs: Toward an HIV Cure. Frontiers in Immunology. 7. 397–397. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026